Items where Author is "Milton, NG"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Article

Chilumuri, A and Ashioti, M and Nercessian, AN and Milton, NG (2013) Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient. Journal of neurodegenerative diseases, 2013. 879710 - ?. ISSN 2090-858X DOI: https://doi.org/10.1155/2013/879710

Chilumuri, A and Milton, NG (2013) The Role of Neurotransmitters in Protection against Amyloid- β Toxicity by KiSS-1 Overexpression in SH-SY5Y Neurons. ISRN neuroscience, 2013. 253210 - ?. DOI: https://doi.org/10.1155/2013/253210

Milton, NG (2012) In Vitro Activities of Kissorphin, a Novel Hexapeptide KiSS-1 Derivative, in Neuronal Cells. Journal of amino acids, 2012. 691463 - ?. ISSN 2090-0104 DOI: https://doi.org/10.1155/2012/691463

Conference or Workshop Item

Werner, S and Martin, S and Paterson, A and Milton, NG (2018) Effects of RVD-hemopressin on amyloid-β induced toxicity in SH-SY5Y neuronal cell culture. In: 8th European Workshop on Cannabinoid Research, 31 August 2017 - 02 September 2017, London.

Milton, NG (2018) Effects of the CB1 cannabinoid receptor antagonist AM281 on kissorphin protection against amyloid-β neurotoxicity. In: 8th European Workshop on Cannabinoid Research, 31 August 2017 - 02 September 2017, London.

Patent

ROEHAMPTON UNIVERSITY (2017) Kissorphin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus. [Patent]

This list was generated on Thu Jul 19 05:14:59 2018 BST.